Back to Browse Journals » ChronoPhysiology and Therapy » Volume 1

Chronomodulated press-coated pulsatile therapeutic system for aceclofenac: optimization of factors influencing drug release and lag time

Authors Sumit Patil, Swati Pund, Amita Joshi, et al

Published Date February 2011 Volume 2011:1 Pages 1—10

DOI http://dx.doi.org/10.2147/CPT.S16504

Published 21 February 2011

Sumit Patil1, Swati Pund2, Amita Joshi2, Chamanlal J Shishoo2, Aliasgar Shahiwala1
1Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad, India; 2Department of Pharmaceutics, BV Patel PERD Centre, Ahmedabad, India

Background: The objective of this study was to develop and evaluate a press-coated pulsatile drug delivery system intended for treatment of early morning stiffness and symptomatic relief from pain in patients with rheumatoid arthritis.
Methods: The formulation involved press coating of a rupturable coat around a rapidly disintegrating core tablet of aceclofenac. A three-factor, two-level, full factorial design was used to investigate the influence of amount of glyceryl behenate, amount of sodium chloride in the coating composition, and the coating level on the responses, ie, lag time to release and amount of aceclofenac released in 450 minutes.
Results: Glyceryl behenate and the coating level had a significant influence on lag time, while sodium chloride helped in the rupture of the coat by acting as a channeling agent. After the coat was ruptured, the core tablet showed a rapid release of aceclofenac due to the presence of Ac-Di-Sol®. Graphical analysis of effects by Lenth's method and Bayesian analysis of coefficients enabled identification of variables active on the selected responses. The optimized formulation comprised 20% w/w glyceryl behenate and 2.2% w/w sodium chloride with a 650 mg coating level, and showed a desired lag time of 358.23 minutes, which mimics the fluctuating symptoms of rheumatoid arthritis, followed by rapid release of aceclofenac.

Keywords: chronotherapy, pulsatile delivery, rupturable coat, aceclofenac
 

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Update on duloxetine for the management of stress urinary incontinence

Maya Basu, Jonathan RA Duckett

Clinical Interventions in Aging 2009, 4:25-30

Published Date: 27 November 2008

Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy

Alan Wright, Kyle E Luedtke, Chad VanDenBerg

Journal of Pain Research 2011, 4:1-10

Published Date: 16 December 2010

Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder

Xianchen Liu, Yi Chen, Douglas E Faries, et al

ClinicoEconomics and Outcomes Research 2011, 3:63-72

Published Date: 15 March 2011

Circadian variations in blood pressure in health and disease: implications for patient management

Chugh AR, Loughran JH, Slaughter MS

ChronoPhysiology and Therapy 2011, 1:17-31

Published Date: 29 August 2011

Predictors of duloxetine adherence and persistence in patients with fibromyalgia

Cui Z, Zhao Y, Novick D, Faries D

Journal of Pain Research 2012, 5:193-201

Published Date: 22 June 2012

Use of select medications prior to duloxetine initiation among commercially-insured patients

Bernauer M, Wu N, Chen SY, Peng X, Boulanger L, Zhao Y

Journal of Pain Research 2012, 5:271-278

Published Date: 14 August 2012

Health locus of control and the sense of self-efficacy in patients with systolic heart failure: a pilot study

Rydlewska A, Krzysztofik J, Libergal J, Rybak A, Banasiak W, Ponikowski P, Jankowska EA

Patient Preference and Adherence 2013, 7:337-343

Published Date: 19 April 2013